Links

The future of economics. Hacker attack on health data.  Where is air pollution highest in low- and middle-income countries. 5.8m children have long COVID Underrated: the HPV vaccine.

Thursday Links

How NICE has applied it’s disease severity modifier. Non-profit hospitals and bond ratings. Calculating cell & gene therapy breakeven point using RWD. Public vs. private Medicaid. Supplementing VA with private insurance.

Links

VR surgery for PPE. SNAP, food insecurity and medication adherence. Hospital racial composition and VBP. Drinking and jobs (part 1, part 2) Geographies with ultra-low fertility.

Links

More people want to expand ACA vs. repeal it. What is a person’s social cost of being corrected by AI? Guidance on the promise and pitfalls of using AI in healthcare. “….people systematically misremember their past policy preferences regarding how to best fight the Covid-19 pandemic” Consequentialists vs. deontologists: “…which moral principle prevails appears to…

Friday Links

Impact of the Great Recession on health. A loneliness epidemic? Medicaid’s increasing pressure on state budgets. Physician reimbursement to decline 3.4%. Are children spending too much time on enrichment activities?

Mid-week Links

ABIM on physician certification. 70.4% of physicians worked while on vacation on a typical vacation day Is Science a public good? Healthcare job growth reached three-decade high. Is there a future for digital therapeutics?

Friday Links

No cervical cancer cases in HPV-vaccinated women. Neuroimaging and mental health care. Syphillis cases on the rise. Dengue Fever vaccine soon to arrive? School spending: “Spending on basic infrastructure (such as HVAC) or on the removal of pollutants raises test scores but not house prices; conversely, spending on athletic facilities raises house prices but not…

Changes to the FDA Advisory Committee process

It appears changes are coming to the FDA Advisory Committee process for evaluating new drugs. The FDA is planning significant reforms to its advisory committee process, as announced by Commissioner Rob Califf. While specifics are scarce, these changes are spearheaded by Namandjé Bumpus, the FDA’s chief scientist, and newly appointed deputy commissioner.Califf noted improvements in…